SEC Form 20-F filed by Immatics N.V.
$IMTX
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/28/2025 | $10.00 | Buy | Deutsche Bank |
| 10/7/2024 | $19.00 | Overweight | Piper Sandler |
| 11/2/2023 | Overweight | Cantor Fitzgerald | |
| 3/31/2023 | $12.00 | Buy | Mizuho |
| 3/24/2023 | $16.00 | Buy | Bryan Garnier |
| 7/15/2021 | $26.00 → $27.00 | Outperform | SVB Leerink |